Overview

Intrathecal Versus Intravenous Dexmeditomedine in Transurethral Resection of the Prostate

Status:
Not yet recruiting
Trial end date:
2021-06-26
Target enrollment:
0
Participant gender:
Male
Summary
This study is to evaluate The analgesic effect of intrathecal versus intravenous dexmeditomedine in transurethral resection of the prostate
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Tanta University
Treatments:
Dexmedetomidine
Criteria
Inclusion Criteria:

- male gender

- 50:70years old

- ASA:I,II

Exclusion Criteria:

- contraindications of spinal anesthesia

- Patient refusal

- Patient taking alpha agonist or antagonist

- Uncontrolled cardiac diseases

- Allergy to local anesthetic drugs